Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 4
2004 1
2005 4
2006 1
2007 5
2008 3
2009 7
2010 8
2011 13
2012 19
2013 15
2014 19
2015 25
2016 18
2017 23
2018 18
2019 13
2020 23
2021 13
2022 8
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Results by year

Filters applied: . Clear all
Page 1
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.
Schito M, Migliori GB, Fletcher HA, McNerney R, Centis R, D'Ambrosio L, Bates M, Kibiki G, Kapata N, Corrah T, Bomanji J, Vilaplana C, Johnson D, Mwaba P, Maeurer M, Zumla A. Schito M, et al. Among authors: maeurer m. Clin Infect Dis. 2015 Oct 15;61Suppl 3(Suppl 3):S102-18. doi: 10.1093/cid/civ609. Clin Infect Dis. 2015. PMID: 26409271 Free PMC article.
Single-cell landscape of immunological responses in patients with COVID-19.
Zhang JY, Wang XM, Xing X, Xu Z, Zhang C, Song JW, Fan X, Xia P, Fu JL, Wang SY, Xu RN, Dai XP, Shi L, Huang L, Jiang TJ, Shi M, Zhang Y, Zumla A, Maeurer M, Bai F, Wang FS. Zhang JY, et al. Among authors: maeurer m. Nat Immunol. 2020 Sep;21(9):1107-1118. doi: 10.1038/s41590-020-0762-x. Epub 2020 Aug 12. Nat Immunol. 2020. PMID: 32788748
Markus Maeurer on the LifeGene project.
Maeurer M. Maeurer M. Expert Rev Clin Immunol. 2010 Sep;6(5):709-12. doi: 10.1586/eci.10.62. Expert Rev Clin Immunol. 2010. PMID: 20828278
Host-directed therapies for COVID-19.
Maeurer M, Ramalho R, Wang FS, Zumla A. Maeurer M, et al. Curr Opin Pulm Med. 2021 May 1;27(3):205-209. doi: 10.1097/MCP.0000000000000769. Curr Opin Pulm Med. 2021. PMID: 33629969 Review.
Immune responses during COVID-19 infection.
Melenotte C, Silvin A, Goubet AG, Lahmar I, Dubuisson A, Zumla A, Raoult D, Merad M, Gachot B, Hénon C, Solary E, Fontenay M, André F, Maeurer M, Ippolito G, Piacentini M, Wang FS, Ginhoux F, Marabelle A, Kroemer G, Derosa L, Zitvogel L. Melenotte C, et al. Among authors: maeurer m. Oncoimmunology. 2020 Aug 25;9(1):1807836. doi: 10.1080/2162402X.2020.1807836. Oncoimmunology. 2020. PMID: 32939324 Free PMC article. Review.
Targeting innate immunity for tuberculosis vaccination.
Khader SA, Divangahi M, Hanekom W, Hill PC, Maeurer M, Makar KW, Mayer-Barber KD, Mhlanga MM, Nemes E, Schlesinger LS, van Crevel R, Vankayalapati R(, Xavier RJ, Netea MG; Bill and Melinda Gates Foundation Collaboration for TB Vaccine Discovery Innate Immunity Working Group18. Khader SA, et al. Among authors: maeurer m. J Clin Invest. 2019 Sep 3;129(9):3482-3491. doi: 10.1172/JCI128877. J Clin Invest. 2019. PMID: 31478909 Free PMC article. Review.
Pregnancy and infection.
Zumla A, Bates M, Maeurer M. Zumla A, et al. Among authors: maeurer m. N Engl J Med. 2014 Sep 11;371(11):1076. doi: 10.1056/NEJMc1408436. N Engl J Med. 2014. PMID: 25207784 Free article. No abstract available.
Cellular therapy in tuberculosis.
Parida SK, Madansein R, Singh N, Padayatchi N, Master I, Naidu K, Zumla A, Maeurer M. Parida SK, et al. Among authors: maeurer m. Int J Infect Dis. 2015 Mar;32:32-8. doi: 10.1016/j.ijid.2015.01.016. Int J Infect Dis. 2015. PMID: 25809753 Free article. Review.
234 results